title: Oncostatin M stimulates urokinase-type plasminogen activator activity in human synovial fibroblasts.
abstract: Cytokine regulation of synovial cell function has been considered to be involved in the pathogenesis of rheumatoid arthritis. Synoviocyte urokinase-type plasminogen activator (u-PA) expression may be relevant to the tissue remodelling, as well as to the cell migration and transformation occurring in rheumatoid joints. We report here that purified recombinant human oncostatin M (greater than or equal to approximately 0.2 U/ml = 1 pM) stimulated within six hr the u-PA activity of non-rheumatoid synovial fibroblast-like cells and raised their u-PA mRNA levels. Oncostatin M could augment PGE2 production and DNA synthesis in these cells; however, the increase in PGE2 was small compared with that caused by IL-1. Since oncostatin M is produced by immune cells, it may have a role in immune and inflammatory reactions by interacting with fibroblast populations, such as synoviocytes, in the manner described.
authors.affiliation: University of Melbourne, Department of Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia.
authors.forename: J A
authors.initials: JA
authors.lastname: Hamilton
authors.forename: T
authors.initials: T
authors.lastname: Leizer
authors.forename: D S
authors.initials: DS
authors.lastname: Piccoli
authors.forename: K M
authors.initials: KM
authors.lastname: Royston
authors.forename: D M
authors.initials: DM
authors.lastname: Butler
authors.forename: M
authors.initials: M
authors.lastname: Croatto
mesh_terms: D000906:Antibodies; D002478:Cells, Cultured; D016207:Cytokines / Q000494:pharmacology*; D004261:DNA Replication / Q000187:drug effects; D015232:Dinoprostone / Q000378:metabolism; D005347:Fibroblasts / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology; D007700:Kinetics; D053683:Oncostatin M; D010455:Peptides / Q000276:immunology / Q000494:pharmacology*; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D011994:Recombinant Proteins / Q000494:pharmacology; D013583:Synovial Membrane / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D014568:Urokinase-Type Plasminogen Activator / Q000235:genetics* / Q000378:metabolism
chemical_list: D000906:Antibodies; D016207:Cytokines; D007375:Interleukin-1; C508351:OSM protein, human; D010455:Peptides; D012333:RNA, Messenger; D011994:Recombinant Proteins; D053683:Oncostatin M; D014568:Urokinase-Type Plasminogen Activator; D015232:Dinoprostone; D007213:Indomethacin